Ranger™ Paclitaxel-Coated PTA Balloon Catheter
Supported by robust clinical evidence, Ranger provides exceptional outcomes, effortless deliverability, and efficient drug transfer.
Eluvia™ Drug-Eluting Vascular Stent System
Eluvia provides consistent, durable outcomes in challenging SFA disease and features a polymer design for controlled drug release.
Eluvia and Ranger are registered or unregistered trademarks of Boston Scientific Corporation or its affiliates. All other trademarks are the property of their respective owners.
Stay Up to Date
Receive emails about the latest drug-eluting technology news, innovations and events in your area.
Explore DE Resources
Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.
2. Versus 87.0% primary patency in the none/mild calcium arm of the IMPERIAL Calcium Subgroup.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for the use only in countries with applicable health authority product registrations. Information not intended for use or distribution in France.
All trademarks are property of their respective owners.